Study Links Glucosamine Supplement Use to Increased Alzheimer's Risk

New research from University of Florida neuroscientists suggests a potential link between the common joint pain supplement glucosamine and an accelerated progression to Alzheimer's disease. Preliminary findings from a large retrospective analysis indicate that individuals taking glucosamine may have a higher likelihood of advancing from mild cognitive impairment. The study highlights a concerning association that warrants further investigation.